An estimated 600,000 American women have hysterectomies every year to treat a variety of non-cancerous conditions.
And although the American Congress of Obstetricians and Gynecologists recommends transvaginal – rather than abdominal — hysterectomy as the safest, least invasive and most cost-effective approach with the fastest recovery time, only 15 to 20 percent of uterus removals are done this way.
Hominis, the surgical robot that acts like a surgeon’s arm
Many more hysterectomies could soon be done vaginally, now that the Hominis robotic surgery system from Israeli company Memic Innovative Surgery has gotten marketing approval from the US Food and Drug Administration and $96 million in Series D investment.
Hominis gets around anatomical barriers that human surgeons can’t, such as pelvic organ prolapse.
“This is what robotics can do,” says Dvir Cohen, CEO and president of Memic. “It’s a fundamental architectural change and there is nothing else like this in the market.”
Hominis is the first FDA-authorized surgical robotic platform with human-level dexterity, flexibility and 360 degrees of articulation.
Its miniature humanoid-shaped robotic arms replicate the motions and capabilities of a surgeon’s hand, shoulder, elbow and wrist joints.
Using a patented surgical method, surgeons operating Hominis can introduce multiple instruments into the body through a single laparoscopic incision, avoiding obstacles and optimizing access and working angles.-- More...
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.
